Showing results (2271-2280 of 2,927) with videos related to

Sort By:
Pageof 293
Cancer Chemotherapy and Pharmacology|September 13, 2014
A first-in-human study of the anti-α5β1 integrin monoclonal antibody PF-04605412 administered intravenously to patients with advanced solid tumorsJ Mateo, J Berlin, J S de Bono, et al.
AIDS Research and Human Retroviruses|July 27, 2019
Treatment and Outcomes of Oropharyngeal Cancer in People with Human Immunodeficiency VirusCristina E Brickman, Kathleen J Propert, Jessica S Merlin, et al.
Plastic and Reconstructive Surgery. Global Open|February 23, 2023
Breast Reconstruction Trends in the Setting of Postmastectomy Radiation Therapy: Analysis of Practices among Plastic Surgeons in the United StatesNima Khavanin, Jerry H Yang, Salih Colakoglu, et al.
Alimentary Pharmacology & Therapeutics|July 15, 2010
Clinical trial: 2-L polyethylene glycol-based lavage solutions for colonoscopy preparation - a randomized, single-blind study of two formulationsL B Cohen, S M Sanyal, C Von Althann, et al.
Cancer Chemotherapy and Pharmacology|December 9, 2010
Sunitinib in combination with paclitaxel plus carboplatin in patients with advanced solid tumors: phase I study resultsElisabeth I Heath, George R Blumenschein, Roger B Cohen, et al.
Vaccine|December 12, 2001
A human volunteer challenge model using frozen bacteria of the new epidemic serotype, V. cholerae O139 in Thai volunteersP Pitisuttithum, M B Cohen, B Phonrat, et al.
Journal of Virology|October 7, 2016
Syncytial Mutations Do Not Impair the Specificity of Entry and Spread of a Glycoprotein D Receptor-Retargeted Herpes Simplex VirusYu Okubo, Hiroaki Uchida, Aika Wakata, et al.
JAMA Otolaryngology-- Head & Neck Surgery|September 22, 2022
Cetuximab-Based vs Carboplatin-Based Chemoradiotherapy for Patients With Head and Neck CancerLova Sun, Danielle Candelieri-Surette, Tori Anglin-Foote, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 17, 2015
Herpes simplex viral-vector design for efficient transduction of nonneuronal cells without cytotoxicityYoshitaka Miyagawa, Pietro Marino, Gianluca Verlengia, et al.
RMD Open|June 9, 2021
Efficacy and safety of tofacitinib modified-release 11 mg once daily plus methotrexate in adult patients with rheumatoid arthritis: 24-week open-label phase results from a phase 3b/4 methotrexate withdrawal non-inferiority study (ORAL Shift)Stanley B Cohen, Janet Pope, Boulos Haraoui, et al.
Pageof 293